Trial NCT00012298

View at ClinicalTrials.gov 
Aliases: NCT01646879
Org. Study IDs: NCI-2009-00008
Secondary IDs: 312 CDR0000068503 MC998C NCI-2009-00008

Last trial update was posted on 2018-08-09

MeSH Interventions

Antibodies, Monoclonal Oprelvekin Rituximab

MeSH Conditions

Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma Lymphoma, B-Cell Lymphoma, B-Cell, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Recurrence Waldenstrom Macroglobulinemia

Other Conditions

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Splenic Marginal Zone Lymphoma Waldenström Macroglobulinemia

Stopping Reasons

Trial completed prematurely.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID